Joinn Laboratories

Founded in 1995, JOINN Laboratories (JOINN, Stock Code: 603127.SH/6127.HK) is a company with a professional team of 1,500 people, dedicated to providing drug R&D CRO outsourcing services. JOINN, headquartered in Beijing, have subsidiaries in Beijing, Suzhou, Chongqing, Wuzhou (GuangXi Province), Guangzhou and Shanghai in China, and Richmond (CA) and Worcester (MA) in the United States. JOINN has built a thorough quality management system complied with the international standard: CNAS/ILAC-MRA certification, NMPA, US FDA, OECD and Korean MFDS GLP certification and international AAALAC accreditation. JOINN can provide customized services tailored to client's specific needs for non-clinical safety assessments, clinical trials, registrations, and pharmacovigilance which cover the entire spectrum from development to final drug registration. JOINN also provides services in animal feed and veterinary medicine evaluation, pesticide evaluation, medical device evaluations, etc. JOINN adheres to the purpose of "serve for drug innovation, focus on safety assessments and monitoring of drugs throughout life cycles". We utilize our unsurpassed capability, profound experience and unremitting efforts to provide our clients with a one-stop and top quality service for the entire process of new drug development and finally realize their ultimate goal - marketing the products.

According to the GICS (Global Industry Classification Standard) version of March 2023, Joinn Laboratories’s industry classification falls within the following categories:

• Sector: -
• Industry group: -
• Industry: -
• Sub-Industry: -